Literature DB >> 7435500

Platelet interaction with bacteria. VI. contrasting the role of fibrinogen and fibronectin.

C C Clawson, J G White, M C Herzberg.   

Abstract

The roles of fibrinogen and fibronectin were contasted in the responses of human platelets to Staphylococcus aureus and collagen. Congenital afibrinogenemic (CA) platelets and washed normal platelets had delayed aggregation due to a prolonged latent phase in response to contact with the bacteria when fibrinogen was absent from the suspending media. When a physiologic level of human fibrinogen was added to the CA platelets in autologous plasma or to the washed platelets in balanced saline, the times to aggregation were significantly shortened (P < 0.05) and restored to rates comparable to those of normal platelets in whole plasma. In contrast, the presence or absence of fibrinogen in the media had no significant effect on the initial adherence and shape-change response of CA or washed platelets to collagen. Platelets with a demonstrated aberration of fibronectin responded normally to all ratios of S aureus, but they responded only to doses of collagen that were several times the threshold levels for normal platelets. These results demonstrate an important role for fibrinogen as a cofactor in platelet interactions with S aureus and indicate that fibronectin is not a major factor in the responses of human platelets to this microorganism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7435500     DOI: 10.1002/ajh.2830090106

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

2.  Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation.

Authors:  Christopher J Kuckleburg; Shaadi F Elswaifi; Thomas J Inzana; Charles J Czuprynski
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  Platelet-interactive products of Streptococcus sanguis protoplasts.

Authors:  M C Herzberg; P R Erickson; P K Kane; D J Clawson; C C Clawson; F A Hoff
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis.

Authors:  A L Cheung; K J Eberhardt; E Chung; M R Yeaman; P M Sullam; M Ramos; A S Bayer
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.

Authors:  A S Bayer; P M Sullam; M Ramos; C Li; A L Cheung; M R Yeaman
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 6.  Salicylic acid: an old dog, new tricks, and staphylococcal disease.

Authors:  Mathias Herrmann
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Cell-free released components of Streptococcus sanguis inhibit human platelet aggregation.

Authors:  M C Herzberg; K L Brintzenhofe; C C Clawson
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.

Authors:  M Herrmann; S J Suchard; L A Boxer; F A Waldvogel; P D Lew
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Aggregation of human platelets and adhesion of Streptococcus sanguis.

Authors:  M C Herzberg; K L Brintzenhofe; C C Clawson
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.